TTrialPathMatch Me to Trials
← Back to trials
RecruitingMigraine

Physiotherapy Intervention for Migraine Symptoms

Eligible age

18–40 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this randomized control trial is to analyse the effectiveness of Physiotherapy intervention among university students with migraine symptoms. The main objective is: 1. To determine the effect of aerobic exercise on the resting-state brainwaves among university students in UTAR with migraine symptoms compared with biofeedback and control exercise. 2. To analyse the influence of aerobic exercise on the sleep quality and quality of life among the cohort compared with biofeedback and control exercise. Although the Migraine Research Foundation listed three main types of non-drug treatments for migraine are lifestyle advice, therapies, and exercises. Some common aerobic exercises such as walking, jogging, a behavioral weight loss program, cycling, and a combination of cross-training, walking, jogging, and cycling are suggested to be beneficial to the migraine patients but there remains no specific protocol established till now. Hence the other main objective of this is to establish a aerobic exercise protocol for patients with migraine symptoms.

Sponsor: Universiti Tunku Abdul Rahman

You may qualify if…

  • Undergraduate, and postgraduate students from Universiti Tunku Abdul Rahman
  • 4 of 5 on the Migraine Screen Questionnaire

You may not qualify if…

  • Score of more than or equal to 5 on the visual aura rating scale,
  • Diagnosed to have a secondary headache (headache attributed to the causative disorder example: infection, trauma, injury to head/ or neck)
  • Pregnancy,
  • Took medication for neurological conditions like stroke, multiple sclerosis and took medications for cardiorespiratory conditions like asthma,
  • Took medications for headache and
  • Unwilling to participate will be excluded

Source: ClinicalTrials.gov · NCT05741775 · last updated 2024-07-01